Shlomo Melmed, MD, ChB, FRCP, MACP, MB

Executive vice president, Academic Affairs

Dean of the medical faculty

Director, Burns and Allen Research Institute

Helene A. and Philip E. Hixon Distinguished Chair in Investigative Medicine

Professor, Medicine

Education

• Medical School: University of Cape Town, 1970
• Internship: Sheba Medical Center, 1972
• Residency: Sheba Medical Center, 1975

Awards and Activities

• Editor-in-chief: Pituitary, current
• Editor: DeGroot and Jameson Endocrinology, current
• Editor: Williams Textbook of Endocrinology, current
• Endocrine Regulation Prize, Foundation IPSEN, 2010
• Transatlantic Medal, Society of Endocrinology, 2010
• President, International Society of Endocrinology, 2004-08
• Endocrine Society Clinical Investigator Award, 2004
• Helene A. and Philip E. Hixon Chair in Investigative Medicine, 2002
• President, Pituitary Society, 2002
• Royal Society of Medicine, Clinical Endocrinology Trust Medal, 1994

Keith L. Black, MD

Chair, Department of Neurosurgery

Director, Maxine Dunitz Neurosurgical Institute

Professor, Neurosurgery

Ruth and Lawrence Harvey Chair in Neuroscience

Research Profile

The research of Keith L. Black, MD, focuses on the biology of the blood-brain barrier and biochemical modulation of the blood-brain tumor barrier, targeted drug delivery, tumor immunology, cancer vaccines, cancer stem cells, microwave tumor ablation, nanotechnology for drug delivery, optical guided surgery for brain tumors and Alzheimer's retinal imaging.

Education

• Medical School: University of Michigan School of Medicine, 1981
• Internship: University of Michigan School of Medicine, 1982
• Residency: University of Michigan School of Medicine, 1987

Awards and Activities

• Editorial Board: Public Library of Science, Current
• Americas Top Doctors and Best Doctors in America, 2007, Current
• Hope of Los Angeles Award, 2012
• National Urban League, Whitney M. Young Jr. Living Legend Award, 2011
• Special Recognition: National Academy of Science, 2000

Itai Danovitch, MD

Chair, Department of Psychiatry and Behavioral Neurosciences

Director, Addiction Psychiatry

Education

• Medical School: David Geffen School of Medicine at UCLA, 2003
• Residency: New York-Presbyterian/Westchester, 2007
• Fellowship: Cedars-Sinai, 2008
• Master's: UCLA Anderson School of Management

David Engman, MD, PhD

Chair, Department of Pathology and Laboratory Medicine

Chair, Academic Pathology

Education

• Medical School: University of Iowa, 1990
• Doctorate: University of Iowa, 1990
• Residency: Northwestern Memorial Hospital, 1995

Awards and Activities

• Established Investigator of the American Heart Association
• Fellow of the American Heart Association
• Member of the American Society for Clinical Investigation
• President of the National Association of MD-PhD Programs
• Member of the American Association of University Pathologists
• Amgen Outstanding Investigator Award of the American Society for Investigative Pathology
• Fellow of the American Academy of Microbiology
• President of the American Association of University Pathologists (Pluto Society)
• Mentor of the Year by the Faculty of the Feinberg School of Medicine

Leon G. Fine, MD

Chair, Department of Biomedical Sciences

Director, Graduate Research Education

Professor, Medicine

Professor, Biomedical Sciences

Vice dean, Research and Graduate Research Education

Research Profile

The principal research interest of Leon G. Fine, MD, is in the biology of chronic renal disease. He has made important contributions to the understanding of adaptations of ion transport in the diseased nephron, renal hypertrophy, and the cell biology of fibrogenesis and scarring of the kidney. His interest has focused on chronic hypoxia as a driving force for organ fibrosis and the possibility of diseased organ regeneration via restoration of microvasculature. He has made contributions to the history of medicine and renal diseases.

Education

• Medical School: University of Cape Town, South Africa, 1966
• Residency: Tel Aviv University, 1968
• Residency: Tel Aviv University, 1970

Awards and Activities

• Academy of Medical Sciences, UK, 1999
• American Society for Clinical Investigation, 1982
• Association of American Physicians, 1998
• Director (nonexecutive), National Institute of Clinical Excellence, 2002
• Editor-in-chief: Experimental Nephrology, 1993-2002

Joel M. Geiderman, MD, FACEP

Co-chair, Department of Medicine

Professor, Emergency Medicine

Education

• Bachelor's: University of Illinois
• Medical School: University of Illinois
• Internship: Northwestern University Medical School
• Residency: Evanston Hospital, Northwestern University

Awards

• Medical Achievement Award, Save a Heart Foundation, 2005
• Friends of Nursing, Cedars-Sinai, 2004
• Medical Visionary Award, Sheba Medical Center, Jerusalem, Israel, 2004
• Jewish Healthcare Foundation Avraham Moshe Bikur Cholim Ahavas Chesed Award, 2000
• United Hostesses Charities "Humanitarian of the Year," 1997

Bruce Gewertz, MD

Chair, Department of Surgery

Chair, Surgery

Director, Division of Vascular Surgery

H & S Nichols Distinguished Chair in Surgery

Professor, Surgery

Surgeon-in-chief

Vice dean, Academic Affairs

Vice president, Interventional Services

Research Profile

The research of Bruce L. Gewertz, MD, focuses on human factors in delivery of healthcare and the distribution of surgical service. His clinical interests include cerebrovascular disease, especially intraoperative neurophysiologic monitoring and outcome analysis, aortic aneurysmal disease and mesenteric ischemic syndromes.

Education

• Medical School: Jefferson Medical College, 1972
• Residency: University of Michigan Hospitals, 1977

Julian A. Gold, MD

Co-chair, Department of Anesthesiology

Education

• Bachelor's: City College of New York (CCNY), 1970
• Medical School: New York University School of Medicine, 1974
• Internship: New York University Medical Center, 1974-1975
• Residency:
  • Surgery - New York Medical Center, 1975-76
  • Anesthesiology - New York Medical Center, 1976-77
  • Chief Resident, Anesthesiology, New York Medical Center, 1977-78
• Fellowship: Cardiac Anesthesia – New York University Medical Center, 1978-79

Sarah J. Kilpatrick, MD, PhD

Chair, Department of Obstetrics and Gynecology

Associate dean, Faculty Development

Helping Hand of Los Angeles Chair in Obstetrics and Gynecology

Research Profile

The clinical and research interests of Sarah Kilpatrick, MD, PhD, include management and outcomes of very preterm birth, as well as maternal morbidity and mortality, and hypertension in pregnancy.

Education

• Medical School: Tulane University School of Medicine, 1985
• Residency: University of California, San Francisco Medical Center, 1989
• Fellowship: University of California, San Francisco Medical Center, 1991

Awards and Activities

• Associate editor: American Journal of Obstetrics and Gynecology, 2006-present
• Editorial board: Contemporary Obstetrics and Gynecology, 2003-present

Patrick D. Lyden, MD

Chair, Department of Neurology

Director, Cedars-Sinai Stroke Center

Carmen and Louis Warschaw Chair in Neurology

Research Profile

The research of Patrick D. Lyden, MD, focuses on translational stroke research. One theme involves understanding the role of thrombin in mediating cytotoxicity during ischemia. In collaboration with Roger Tsien, PhD, at University of California, San Diego and other colleagues, Lyden's research has shown that during a stroke, thrombin enters the brain, adheres to neurons, and kills them via the protease activated receptor. His research also has shown that thrombin inhibitors block this cytotoxicity and ameliorate the behavioral and histological effects of stroke. Recently, Lyden and his colleagues have shown that the thrombin inhibitor argatroban powerfully protects the brain when delayed as long as three hours after stroke. Future studies are aimed at understanding the mechanism by which thrombin enters brain and whether thrombin plays any other roles, such as pre-conditioning. A second theme involves treating stroke with hypothermia. Lyden and his colleagues propose to address critical questions about cooling target depth, duration and delay-time window, and to develop new tools for translational studies in this field. He aims to determine the relationship among target depth, duration and delay, and to develop new models for conducting further research into therapeutic hypothermia, considered the most potent putative neuroprotectant available.

Education

• Internship: Mercy Hospital and Medical Center, 1982
• Residency: University of California, San Diego School of Medicine, 1985
• Fellowship: University of California, San Diego School of Medicine, 1987

Awards and Activities

• Associate editor: The International Journal of Stroke, current
• Editorial board: Stroke, current
• Editorial board: Therapeutic Hypothermia and Temperature Management, current
• Peer reviewer: Science Translational Medicine, current
• Peer reviewer: The Lancet, current

Eduardo Marbán, MD, PhD

Director, Cedars-Sinai Heart Institute

Professor of Medicine

Research Focus

The research of Eduardo Marbán, MD, PhD, uses biologically based therapies for cardiac regeneration and biological pacemakers. All lab members have a specific role in conducting their research that will enable the Marbán Lab to translate their work from the bench to bedside. The research using cardiosphere-derived cells has demonstrated that cells are better in their functional repair capacity and in their angiogenic ability to secrete favorable paracrine factors that other cells currently in clinical use do not. The lab is studying methods of delivering the cells and determining the immunogenicity of allogeneic stem cells in small- and large-animal models.

Research Contributions

Marbán elucidated the fundamental mechanisms of cardiac dysfunction in stunned myocardium and other conditions related to ischemia and heart failure; founded the field of biological therapy for cardiac arrhythmias, notably gene-engineered biopacemakers; and developed preclinical methods for isolation of cardiac stem cells, leading to their clinical application in patients.

Awards and Activities

• Award for Outstanding Contribution to Cardiovascular Research, Gill Heart Institute, 2006
• Distinguished Scientist Award, American Heart Association, 2004
• Research Achievement Award, International Society for Heart Research, 2001
• Basic Research Prize, American Heart Association, 2000
• Louis and Arthur Lucian Award for Research in Circulatory Diseases, 1998
• Research Career Development Award, National Institutes of Health (NIH), 1986
• Editor-in-Chief: Circulation Research, 1999-2009

Paul Noble, MD

Chair, Department of Medicine

Director, Women's Guild Lung Institute

Vera and Paul Guerin Distinguished Chair in Pulmonary Medicine

The clinical areas of expertise of Paul Noble, MD, are interstitial lung disease, conducting clinical trials in idiopathic pulmonary fibrosis, connective tissue disease-related pulmonary disease and brochiolitis. His research focuses on cellular and molecular mechanisms of lung inflammation and fibrosis, the role of lung stem cells in pulmonary fibrosis and the role of host defense in lung inflammation and fibrosis. His research is heavily supported by the National Heart, Lung and Blood Institute at the National Institutes of Health.

Prior to joining Cedars-Sinai, Noble was a Charles Johnson, MD, Distinguished Professor and Chief of the Division of Pulmonary, Allergy and Critical Care Medicine at Duke University Medical Center in Durham, North Carolina.

As an assistant professor of medicine at The Johns Hopkins University School of Medicine, he was founder and director of the Interstitial Lung Disease Clinic, before moving on to become professor of medicine and associate chief of pulmonary and critical care at Yale University School of Medicine. At Yale, he also formed an interstitial lung disease clinic, and at Duke, he propelled his division to the highest ranks in the nation for clinical care, research productivity and National Institutes of Health funding.

Education

• Bachelor's: Haverford College
• Medical School: New York University School of Medicine
• Residency/Chief Residency: University of California, San Francisco
• Fellowships in Pulmonary and Critical Care: University of Colorado Health Sciences Center; National Jewish Center for Immunology and Respiratory Medicine

Awards and Activities

• Original research published in numerous peer-reviewed journals, including the New England Journal of Medicine, Scienceand Nature Medicine.
• Deputy editor: Journal of Clinical Investigation
• Elected member: American Society of Clinical Investigation
• Elected member: American Association of Physicians
• Deputy editor: Journal of Clinical Investigation
• Editorial board: American Journal of Respiratory Cell and Molecular Biology
• Editorial board: American Journal of Respiratory and Critical Care Medicine
• Member of the scientific advisory board: American Asthma Foundation

Dan Theodorescu, MD, PhD

Director, Samuel Oschin Comprehensive Cancer Institute

PHASE ONE Foundation Distinguished Chair

Barry D, Pressman, MD

Chair, Department of Imaging, S. Mark Taper Foundation Imaging Center

Professor, Imaging

Chief, Neuroradiology; Head and Neck Radiology

Education

• Medical School: Harvard Medical School
• Internship: Harvard's Peter Bent Brigham Hospital
• Diagnostic Radiology Residency: Columbia-Presbyterian Medical Center
• Neuroradiology Fellowship: George Washington University Hospital

Richard V. Riggs, MD

Chair, Department of Physical Medicine and Rehabilitation

Vice president, chief medical information officer

Education

• Medical School: Medical College of Georgia, 1988
• Internship: Johns Hopkins University, 1989
• Residency: University of Pennsylvania, 1992

Awards and Activities

• Reviewer: Physical Medicine and Rehabilitation Journal, current
• Golden Apple Teaching Award, 2007
• Southern California Stroke Association, 2006

Howard M. Sandler, MD

Chair, Department of Radiation Oncology

Chair, Radiation Oncology

Professor, Radiation Oncology

Ronald H. Bloom Family Chair in Cancer Therapeutics

Research Profile

Howard M. Sandler, MD, is principal investigator for a national Radiation Therapy Oncology Group study examining radiotherapy and chemotherapy for prostate cancer. He recently led a clinical trial grant funded by the National Institutes of Health to investigate novel radiation targeting strategies for prostate cancer. His studies also include evaluating the quality of life of prostate cancer patients following surgery and radiation therapy.

Education

• Medical School: University of Connecticut School of Medicine, 1985
• Internship: St. Francis Hospital, 1986
• Residency: Hospital of the University of Pennsylvania, 1989

Awards and Activities

• Chair, NRG Oncology/RTOG Genitourinary Cancer Committee, 1997
• Program Chair, 2010 ASCO-ASTRO-SUO Genitourinary Cancer Symposium, 2008

Charles F. Simmons, MD

Chair, Department of Pediatrics

Director, Neonatology

Professor, Pediatrics

Ruth and Harry Roman Chair in Neonatology in honor of Larry Baum

Research Profile

Charles Simmons, MD, supports mission-critical clinical program development, education and research in neonatal-perinatal medicine. He seeks to improve the health of newborns via precision newborn medicine, prevent common complications of prematurity and train future leaders in newborn medicine. Under Simmons' leadership, new programs in the Cedars-Sinai Neonatal Intensive Care Unit (NICU) diagnose, treat and prevent disease in the newborn period, and bring innovative NICU educational experiences to trainees and audiences around the globe. Also, they leverage additional extramural philanthropic and grant resources to further advance newborn health. Simmons' clinical and translational research involves prevention of preterm birth (improving the outcomes of assisted reproductive technologies), developmental innate immunity (immunologic stratification for maternal risk of preterm birth), regenerative medicine (a newborn biorepository of induced pluripotent stem cells, and new potential therapies to prevent or treat cerebral palsy), NICU genetic biorepositories (clinical ethics of biorepositories from newborns in the NICU) and precision newborn medicine (improving the value of NICU healthcare through personalized neonatal nutrition, preventing retinopathy of prematurity, developing strategies for universal newborn ophthalmology screening, new minimally invasive, collaborative strategies to treat patent ductus, arteriosus, and exosome-based diagnostics).

Education

• Medical School: Harvard Medical School, 1980
• Residency: Children's Hospital, Boston, 1983
• Fellowship: Children's Hospital, Boston, 1986
• Fellowship: Dana-Farber Cancer Institute, 1986

Awards and Activities

• Best Doctors, 2005-present
• Super Doctors, 2005-present
• Castle Connolly America's Top Doctors, 2005-present
• Patient's Choice Award, 2005-present
• American Pediatric Society, 2009
• President, California Association of Neonatologists, 2008-09
• Ruth and Harry Roman Chair in Neonatology in honor of Larry Baum, 2002
• FIRST Award, NIH/National Institute of Child Health and Human Development (NICHD), 1996
• Hearst Foundation Award, Harvard Medical School, 1994
• Milton Fund Award, Harvard Medical School, 1993
• Clinical Investigator Award, NIH/NICHD, 1987
• Charles A. Janeway Award, Children's Hospital. Boston, 1984
• Harold Lamport Biomedical Research Award, Harvard Medical School, 1980
• Magna cum laude graduate, Harvard Medical School, 1980

Clive Svendsen, PhD

Director, Board of Governors Regenerative Medicine Institute

Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine

Professor, Medicine

Professor, Biomedical Sciences

Research Profile

Clive Svendsen, PhD, did his pre-doctoral training at Harvard University. He received his PhD from the University of Cambridge in England, where he then established a stem cell research group before moving to the University of Wisconsin in 2000 to become professor of Neurology and Anatomy, director of a stem cell training program funded by the National Institutes of Health and co-director of the University of Wisconsin Stem Cell and Regenerative Medicine Center. In 2010, he moved to Los Angeles to establish and direct the Cedars-Sinai Regenerative Medicine Institute, which has 15 faculty members and approximately 100 staff. One focus of his current research is to derive cells from patients with specific disorders, which can then be "reprogrammed" to a primitive state and used as powerful models of human disease. Svendsen led the first groups to successfully model both spinal muscular atrophy and more recently Huntington’s disease using this technology. The other side of his research involves leading-edge clinical trials. He was involved with one of the first growth factor treatments for Parkinson’s disease and is now working closely with neurosurgeons, neurologists and other scientists to develop novel ways of using stem cells modified to release powerful growth factors to treat patients with neurological diseases such as amyotrophic lateral sclerosis, Huntington’s, Alzheimer’s and Parkinson’s.

Education

• Undergraduate: King's College London, 1983
• Doctorate: Jesus College, Cambridge, 1991

Awards and Activities

• Board, Emulate Incorporated, Organ on a Chip Company, Current
• Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine, 2014
• Shelia Essey Award, American Academy of Neurology, 2010
• Huntington Disease Trailblazer Award, Huntington's Disease Society of America, 2009
• Statuette Award, International Academy for Child Brain Development, 2006
• Bernard Sanberg Memorial Award for Brain Repair, 2005

Sam S. Torbati, MD, FAAEM, FACEP

Co-chair, Department of Emergency Medicine

Associate professor, Emergency Medicine

Education

• Bachelor's: UCLA
• Medical School: University of California, San Diego
• Internship: Mercy Hospital and Medical Center, San Diego
• Residency: University of California, San Diego

Awards and Activities

• Clinician of the Year, Department of Emergency Medicine, Cedars-Sinai, 2012
• America's Top Emergency Physicians, Consumer Research Council of America, 2006-211
• Outstanding Academic Achievement, UCSD Department of Emergency Medicine, 2000
• Outstanding Intern of the Year, Mercy Hospital and Medical Center, 1997
• Outstanding Pediatric Intern of the Year, Mercy Hospital and Medical Center, 1997
• Lambrechs Scholarship, 1995
• Mackenzie Scholarship, 1995
• Emil Adler Scholarship, 1995
• Hillyer Scholarship, 1994
• California Academy of Family Physicians Syntex Laboratory Award, 1993
• UCSD Summer Preceptorship Award, 1993
• Golden Key National Honors Society, 1991
• Psi Chi National Honors Society, 1990

Ronald H. Wender, MD

Co-chair, Department of Anesthesiology

Education

• Medical School: Tulane University School of Medicine, 1973
• Internship: Pediatrics: Los Angeles County-USC, 1974
• Residency: UCLA School of Medicine, Anesthesiology 1976

Awards and Activities

• Outstanding Faculty Award for Didactic Teaching, 2009-10
• Career Advice and Words of Wisdom, 2012-13
• Coach of the Year, 2013-14
• Humanitarian Award, Presented by the United Hostesses Charities, 2005
• Past president, Medical Board of California
• Consultant to the executive director, Medical Board of California
• Member, Medical Board of California Drug Diversion Task Force
• Member, Western Anesthesia Chairman's Committee (all Western academic programs from Colorado to California) for Residency Programs
• Board of Directors for AAASF Accreditation Body for Stand Alone Surgery Centers, nationally
• Member, Board of Governors of the Doctor's Company
• Consultant, American Society of Plastic Surgery